Both in Pharmaceuticals
NextCure vs Filana Therapeutics
Over the past year NXTC returned −16.4% and FLNA returned −26.0%; their daily moves had a correlation of 0.03.
NXTC −16.4% FLNA −26.0%Growth of $1, one year, split-adjusted
| Metric | NXTC | FLNA |
|---|---|---|
| Price | $5.85 | $0.5720 |
| Market cap | $26.8M | $27.6M |
| Today | −1.02% | −3.75% |
| 1 month | +2.9% | −34.6% |
| 6 months | −45.4% | — |
| Year to date | −58.8% | — |
| 1 year | −51.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.1M | $82.7M |
| Dividend yield | — | — |
| Volatility (60d) | 111.0% | — |
| Short % of float | 8.4% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).